Ercros SA
MAD:ECR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its 3-Year Average (5.2), the stock would be worth €-3.03 (189% downside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -5.8 | €3.42 |
0%
|
| 3-Year Average | 5.2 | €-3.03 |
-189%
|
| 5-Year Average | 5.5 | €-3.21 |
-194%
|
| Country Average | 13.8 | €-8.06 |
-336%
|
Forward P/E
Today’s price vs future net income
| Today's Market Cap | Net Income | Forward P/E | ||
|---|---|---|---|---|
|
€313.6m
|
/ |
Jan 2026
€-53.6m
|
= |
|
|
€313.6m
|
/ |
Dec 2026
€-23.1m
|
= |
|
|
€313.6m
|
/ |
Dec 2027
€-15.7m
|
= |
|
|
€313.6m
|
/ |
Dec 2028
€923.5k
|
= |
|
Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| ES |
|
Ercros SA
MAD:ECR
|
312.7m EUR | -5.8 | |
| SA |
|
Saudi Basic Industries Corporation SJSC
SAU:2010
|
228.3B SAR | -8.8 | |
| ID |
|
Chandra Asri Pacific PT Tbk
OTC:PTPIF
|
45.6B USD | 41.8 | |
| US |
|
Dow Inc
NYSE:DOW
|
28.4B USD | -11.1 | |
| ID |
|
Chandra Asri Petrochemical Tbk PT
IDX:TPIA
|
458.5T IDR | 24.8 | |
| UK |
|
LyondellBasell Industries NV
NYSE:LYB
|
23.6B USD | -32 | |
| TW |
|
Nan Ya Plastics Corp
TWSE:1303
|
726.5B TWD | 160.8 | |
| CN |
|
Hengli Petrochemical Co Ltd
SSE:600346
|
156.4B CNY | 17.5 | |
| KR |
|
LG Chem Ltd
KRX:051910
|
31.9T KRW | -17.5 | |
| CN |
|
Rongsheng Petrochemical Co Ltd
SZSE:002493
|
136.3B CNY | 185.1 | |
| CN |
G
|
Guangzhou Tinci Materials Technology Co Ltd
SZSE:002709
|
120.7B CNY | 42.1 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 11 |
| Median | 13.8 |
| 70th Percentile | 20.2 |
| Max | 2 945.9 |
Other Multiples
Ercros SA
Glance View
Ercros SA engages in the manufacture and commercialization of chemical products. The company is headquartered in Barcelona, Barcelona and currently employs 1,321 full-time employees. The Company’s products are structured into three business lines: Businesses Associated to Chlorine, which comprises the production of chlorine, ethyl acetate, caustic soda, sodium hypochlorite, dichloroethane, chloromethane, sodium chlorate and caustic potash, polyvinyl chloride (PCV), as well as water disinfectants; Intermediate Chemicals, which produces formaldehyde, glues and resins for the fiberboard and plywood industries, and Pharmaceuticals, which comprises raw material and intermediate products used in the pharmaceutical industry. The firm owns such subsidiaries as Marcoating SLU, Gades Ltd and Ercekol AIE, among others. In April 2014, it sold Fosfatos de Cartagena SLU to Timab Iberica.
